Abstract: The present invention comprises a composition and method treating eye diseases using a composition having a therapeutically effective amount of a progestagen and a pharmaceutically acceptable carrier, wherein the composition is applied to the palpebral part of the eye and/or ocular surface.
Type:
Application
Filed:
December 23, 2013
Publication date:
April 24, 2014
Applicant:
Rhodes Pharmaceuticals, LP
Inventors:
Charles Gerald Connor, Charles L. Haine